Idiopathic Angioedema: Current Challenges

References

• Bouillet L, Boccon-Gibod I, Berard F, Nicolas JF Recurrent angioedema: diagnosis strategy and biological aspects. Eur J Dermatol. 2014; 24:293–296. doi:10.1684/ejd.2014.227624723651
   PubMed Web of Science ®Google Scholar
• Radonjic-Hoesli S, Hofmeier KS, Micaletto S, Schmid-Grendelmeier P, Bircher A, Simon D. Urticaria and angioedema: an update on classification and pathogenesis. Clin Rev Allergy Immunol. 2018; 54:88–101. doi:10.1007/s12016-017-8628-1.28748365
   PubMed Web of Science ®Google Scholar
• Kelly M, Donnelly JP, McAnnally J-R, Wang HE National estimates of emergency department visits for angioedema and allergic reactions in the United States. Allergy Asthma Proc. 2013; 34:150‑4. doi:10.2500/aap.2013.34.3640.
   Web of Science ®Google Scholar
• Crochet J, Lepelley M, Yahiaoui N, et al. Bradykinin mechanism is the main responsible for death by isolated asphyxiating angioedema in France. Clin Exp Allergy. 2019; 49:252–254. doi:10.1111/cea.13297.30326160
   PubMed Web of Science ®Google Scholar
• Faisant C, Boccon-Gibod I, Mansard C, et al. Idiopathic histaminergic angioedema without wheals: a case series of 31 patients. Clin Exp Immunol. 2016; 185:81–85. doi:10.1111/cei.12789.26969870
   PubMed Web of Science ®Google Scholar
• Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018; 73:1393–1414. doi:10.1111/all.13397.29336054
   PubMed Web of Science ®Google Scholar
• Kanani A, Betschel SD, Warrington R Urticaria and angioedema. Allergy Asthma Clin Immunol. 2018; 14:59. doi:10.1186/s13223-018-0288-z.30263036
   PubMed Web of Science ®Google Scholar
• Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria A GA2LEN task force report. Allergy. 2011; 66:317–330. doi:10.1111/all.2011.66.issue-3.21083565
   PubMed Web of Science ®Google Scholar
• Staevska M, Popov TA, Kralimarkova T, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010; 125:676–682. doi:10.1016/j.jaci.2009.11.047.20226302
   PubMed Web of Science ®Google Scholar
• Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014; 69:602–616. doi:10.1111/all.12380.24673465
   PubMed Web of Science ®Google Scholar
• Oschatz C, Maas C, Lecher B, et al. Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo. Immunity. 2011;34:258–268. doi:10.1016/j.immuni.2011.02.008.21349432
   PubMed Web of Science ®Google Scholar
• Sands MF, Blume JW, Schwartz SA Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol. 2007;120:979–981. doi:10.1016/j.jaci.2007.07.041.17931567
   PubMed Web of Science ®Google Scholar
• von Websky A, Reich K, Steinkraus V, Breuer K Complete remission of severe chronic recurrent angioedema of unknown cause with omalizumab. J Dtsch Dermatol Ges. 2013;11:677–678. doi:10.1111/ddg.2013.11.issue-7.23575040
   PubMed Web of Science ®Google Scholar
• Ozturk AB, Kocaturk E Omalizumab in recurring larynx angioedema: a case report. Asia Pac Allergy. 2014;4:129–130. doi:10.5415/apallergy.2014.4.2.129.24809020
   PubMedGoogle Scholar
• Azofra J, Díaz C, Antépara I, Jaúregui I, Soriano A, Ferrer M Positive response to omalizumab in patients with acquired idiopathic nonhistaminergic angioedema. Ann Allergy Asthma Immunol. 2015;114:418–419. doi:10.1016/j.anai.2015.02.007.25747788
   PubMed Web of Science ®Google Scholar
• Faisant C, Du Thanh A, Mansard C, Deroux A, Boccon-Gibod I, Bouillet L. Idiopathic non-histaminergic angioedema: successful treatment with omalizumab in five patients. J Clin Immunol. 2017;37:80–84. doi:10.1007/s10875-016-0345-7.27826875
   PubMed Web of Science ®Google Scholar
• Bucher MC, Petkovic T, Helbling A, Steiner UC Idiopathic non-histaminergic acquired angioedema: a case series and discussion of published clinical trials. Clin Transl Allergy. 2017;7:27. doi:10.1186/s13601-017-0164-9.28861213
   PubMed Web of Science ®Google Scholar
• Brunetta E, Shiffer D, Folci M, et al. Omalizumab for idiopathic nonhistaminergic angioedema: evidence for efficacy in 2 patients. Case Rep Immunol. 2018: 8067610.
   Web of Science ®Google Scholar
• Kaplan AP, Giménez-Arnau AM, Saini SS Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017;72:519–533.27861988
   PubMed Web of Science ®Google Scholar
• Kolkhir P, André F, Church MK, Maurer M, Metz M Potential blood biomarkers in chronic spontaneous urticaria. Clin Exp Allergy. 2017;47:19–36. doi:10.1111/cea.2017.47.issue-1.27926978
   PubMed Web of Science ®Google Scholar
• Lara-Marquez ML, Christiansen SC, Riedl MA, Herschbach J, Zuraw BL Threshold-stimulated kallikrein activity distinguishes bradykinin- from histamine-mediated angioedema. Clin Exp Allergy. 2018;48:1429–1438. doi:10.1111/cea.2018.48.issue-11.29957871
   PubMed Web of Science ®Google Scholar
• Arm JP, Bottoli I, Skerjanec A, et al. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects. Clin Exp Allergy. 2014;44:1371–1385. doi:10.1111/cea.12400.25200415
   PubMed Web of Science ®Google Scholar
• Martinez-Saguer I, Farkas H Erythema marginatum as an early symptom of hereditary angioedema: case report of 2 newborns. Pediatrics. 2016;137:e20152411. doi:10.1542/peds.2015-2411.26759410
   PubMed Web of Science ®Google Scholar
• Bork K, Staubach P, Eckardt AJ, Hardt J Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol. 2006;101:1–9. doi:10.1111/ajg.2006.101.issue-3.
   Web of Science ®Google Scholar
• Veronez CL, Campos RA, Constantino-Silva RN, Nicolicht P, Pesquero JB, Grumach AS Hereditary angioedema-associated acute pancreatitis in C1-inhibitor deficient and normal C1-inhibitor patients: case reports and literature review. Front Med. 2019;6:80. doi:10.3389/fmed.2019.00080.
   Web of Science ®Google Scholar
• Bork K, Bernstein JA, Machnig T, Craig TJ Efficacy of different medical therapies for the treatment of acute laryngeal attacks of hereditary angioedema due to C1-esterase inhibitor deficiency. J Emerg Med. 2016;50:567e1–580e1. doi:10.1016/j.jemermed.2015.11.008.26826769
   PubMed Web of Science ®Google Scholar
• Longhurst H, Cicardi M Hereditary angioedema. Lancet. 2012;379:474‑81. doi:10.1016/S0140-6736(11)60935-5.
   Web of Science ®Google Scholar
• Maurer M, Magerl M, Ansotegui I, et al. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update. Allergy. 2018;73:1575–1596. doi:10.1111/all.2018.73.issue-8.29318628
   PubMed Web of Science ®Google Scholar
• Farkas H, Veszeli N, Kajdácsi E, Cervenak L, Varga L Nuts and Bolts” of laboratory evaluation of angioedema. Clin Rev Allergy Immunol. 2016;51:140–151. doi:10.1007/s12016-016-8539-6.27142368
   PubMed Web of Science ®Google Scholar
• Zanichelli A, Arcoleo F, Barca MP, et al. A nationwide survey of hereditary angioedema due to C1Inhibitor deficiency in Italy. Orphanet J Rare Dis. 2015; 10:11. doi:10.1186/s13023-015-0233-x.25758562
   PubMed Web of Science ®Google Scholar
• Banerji A Hereditary angioedema: classification, pathogenesis, and diagnosis. Allergy Asthma Proc. 2011; 32:403–407. doi:10.2500/aap.2011.32.3492.22221432
   PubMed Web of Science ®Google Scholar
• Germenis AE, Speletas M Genetics of hereditary angioedema revisited. Clin Rev Allergy Immunol. 2016;51:170–182. doi:10.1007/s12016-016-8543-x.27116602
   PubMed Web of Science ®Google Scholar
• Gobert D, Paule R, Ponard D, et al. A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients. Medicine (Baltimore). 2016;95:e4363. doi:10.1097/MD.0000000000004363.27537564
   PubMed Web of Science ®Google Scholar
• Castelli R, Zanichelli A, Cicardi M, Cugno M Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship. Crit Rev Oncol Hematol. 2013;87:323–332. doi:10.1016/j.critrevonc.2013.02.004.23490322
   PubMed Web of Science ®Google Scholar
• Calvo-Ferrer MA, Martín-Rodríguez S, Ortega-Unanue N, ÁJ B-S, Bernardo-González I A novel variant in SERPING1 gene causing angioedema in a patient with C1q low levels. Ann Allergy Asthma Immunol. 2019; 27.
   Web of Science ®Google Scholar
• Mete Gökmen N, Gülbahar O, Onay H, et al. Deletions in SERPING1 lead to lower C1 inhibitor function: lower C1 inhibitor function can predict disease severity. Int Arch Allergy Immunol. 2019;178:50–59. doi:10.1159/000492583.30278448
   PubMed Web of Science ®Google Scholar
• Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore). 2003;82:274–281. doi:10.1097/01.md.0000085055.63483.09.12861105
   PubMed Web of Science ®Google Scholar
• Cacoub P, Frémeaux-Bacchi V, De Lacroix I, et al. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum. 2001;44:1836–1840. doi:10.1002/1529-0131(200108)44:8<1836::AID-ART321>3.0.CO;2-Y.11508436
   PubMed Web of Science ®Google Scholar
• Binkley KE, Davis A Clinical, biochemical, and genetic characterization of a novel estrogen- dependent inherited form of angioedema. J Allergy Clin Immunol. 2000;106:546‑50. doi:10.1067/mai.2000.108106.
   Web of Science ®Google Scholar
• Dewald G, Bork K Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun. 2006;343:1286–1289. doi:10.1016/j.bbrc.2006.03.092.16638441
   PubMed Web of Science ®Google Scholar
• Bork K, Wulff K, Steinmüller-Magin L, et al. Hereditary angioedema with a mutation in the plasminogen gene. Allergy. 2017.
   Google Scholar
• Bafunno V, Firinu D, D’Apolito M, et al. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema. J Allergy Clin Immunol. 2018;141(3):1009‑17.
   Web of Science ®Google Scholar
• Deroux A, Boccon-Gibod I, Fain O, et al. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Clin Exp Immunol. 2016;185(3):332‑7.
   Web of Science ®Google Scholar
• Veronez CL, Moreno AS, Constantino-Silva RN, et al. Hereditary angioedema with normal C1 inhibitor and F12 mutations in 42 Brazilian families. J Allergy Clin Immunol Pract. 2018;6(4):1209–1216.e8. doi:10.1016/j.jaip.2017.09.025.29128335
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu S, Lin C, et al.Compound heterozygous mutations Glu502Lys and Met527Thr of the FXII gene in a patient with factor XII deficiency. Hematol Amst Neth. 2019;24(1):420‑5.
   Google Scholar
• Picone O, Donnadieu AC, Brivet FG, Boyer-Neumann C, Frémeaux-Bacchi V, Frydman R Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene. Obstet Gynecol Int. 2010; 2010: 957507. doi:10.1155/2010/957507.20490261
   PubMedGoogle Scholar
• Wintenberger C, Boccon-Gibod I, Launay D, et al.Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients. Clin Exp Immunol. 2014;178:112–117. doi:10.1111/cei.2014.178.issue-1.
   Web of Science ®Google Scholar
• Belbézier A, Hardy G, Marlu R, et al.Plasminogen gene mutation with normal C1 inhibitor hereditary angioedema: three additional French families. Allergy. 2018;73:2237–2239. doi:10.1111/all.2018.73.issue-11.29952006
   PubMed Web of Science ®Google Scholar
• Germenis AE, Loules G, Zamanakou M, et al.On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema. Allergy. 2018;73:1751–1753. doi:10.1111/all.2018.73.issue-8.30009523
   PubMed Web of Science ®Google Scholar
• Recke A, Massalme EG, Jappe U, et al.Identification of the recently described plasminogen gene mutation p.Lys330Glu in a Family from Northern Germany with Hereditary Angioedema. Clin Transl Allergy. 2019;9:9.
   Google Scholar
• Yakushiji H, Hashimura C, Fukuoka K, et al. A missense mutation of the plasminogen gene in hereditary angioedema with normal C1 inhibitor in Japan. Allergy. 2018;73(11):2244‑7. doi:10.1111/all.2018.73.issue-11.
   Web of Science ®Google Scholar
• Bork K, Wulff K, Rossmann H, et al. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin. Allergy. 2019. doi:10.1111/all.v74.12.
   Web of Science ®Google Scholar
• Brown NJ, Ray WA, Snowden M, Griffin MR Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60:8–13. doi:10.1016/S0009-9236(96)90161-7.8689816
   PubMed Web of Science ®Google Scholar
• Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension. 2009;54:516–523. doi:10.1161/HYPERTENSIONAHA.109.134197.19581505
   PubMed Web of Science ®Google Scholar
• Duerr M, Glander P, Diekmann F, Dragun D, Neumayer -H-H, Budde K. Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients. Clin J Am Soc Nephrol. 2010;5:703–708. doi:10.2215/CJN.07371009.20093343
   PubMed Web of Science ®Google Scholar
• Baş M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015;372:418–425. doi:10.1056/NEJMoa1312524.25629740
   PubMed Web of Science ®Google Scholar
• Roberts JR, Lee JJ, Marthers DA Angiotensin-converting enzyme (ACE) inhibitor angioedema: the silent epidemic. Am J Cardiol. 2012;109:774–775. doi:10.1016/j.amjcard.2011.11.014.22364704
   PubMed Web of Science ®Google Scholar
• Veronez CL, Serpa FS, Pesquero JB A rare mutation in the F12 gene in a patient with ACE inhibitor-induced angioedema. Ann Allergy Asthma Immunol. 2017;118:743‑5. doi:10.1016/j.anai.2017.04.014.
   Web of Science ®Google Scholar
• Faisant C, Armengol G, Bouillet L, et al. Angioedema triggered by medication blocking the renin/angiotensin system: retrospective study using the french national pharmacovigilance database. J Clin Immunol. 2016;36:95–102. doi:10.1007/s10875-015-0228-3.
   Web of Science ®Google Scholar
• Du-Thanh A, Raison-Peyron N, Drouet C, Guillot B Efficacy of tranexamic acid in sporadic idiopathic bradykinin angioedema. Allergy. 2010;65:793‑5.
   Web of Science ®Google Scholar
• Fok JS, Katelaris CH Angioedema masqueraders. Clin Exp Allergy. 2019;49:1274–1282. doi:10.1111/cea.v49.10.31310036
   PubMed Web of Science ®Google Scholar
• Deroux A, Dumestre-Perard C, Khalil-Mgharbel A, et al. BIOBRAD study: the search for biomarkers of bradykinin-mediated angio-oedema attacks. Int Arch Allergy Immunol. 2016;170:108–114. doi:10.1159/000446959.27475458
   PubMed Web of Science ®Google Scholar
• Kaplan AP, Maas C The search for biomarkers in hereditary angioedema. Front Med. 2017;4:206. doi:10.3389/fmed.2017.00206.
   Web of Science ®Google Scholar
• Veszeli N, Kőhalmi KV, Kajdácsi E, et al. Complete kinetic follow-up of symptoms and complement parameters during a hereditary angioedema attack. Allergy. 2018;73:516–520. doi:10.1111/all.13327.28986975
   PubMed Web of Science ®Google Scholar
• Bouillet L, Vilgrain IV E-cadherin, a potential marker for endothelial cell activation during hereditary angioedema attacks. J Allergy Clin Immunol. 2014;134:241. doi:10.1016/j.jaci.2014.04.016.
   Web of Science ®Google Scholar